Cornerstone Capital Management Holdings’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-10,900	Closed	-$101K	–	1401
2016 Q4	$101K	Sell	10,900 -15,654	-59%	-$141K	﹤0.01%	1242
2016 Q3	$259K	Buy	26,554 +8,354	+46%	+$113K	﹤0.01%	1163
2016 Q2	$258K	Sell	18,200 -400	-2%	-$6.24K	﹤0.01%	1159
2016 Q1	$260K	Buy	18,600 +17,800	+2,225%	+$261K	﹤0.01%	1167
2015 Q4	$16K	Buy	+800	New	+$12.3K	﹤0.01%	1417

Other funds holding AGTC

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cornerstone Capital Management Holdings's AGTC Position: Q1 2017 in Review

Cornerstone Capital Management Holdings sold out of Applied Genetic Technologies Corporation (AGTC) in Q1 2017, closing a stake of 10,900 shares — an estimated $101K sold.

Cornerstone Capital Management Holdings first reported a position in AGTC in Q4 2015 and held it in 5 quarters. The position peaked at $260K in Q1 2016. 89 funds tracked by Wall St. Rank hold AGTC as of Q1 2017.

Cornerstone Capital Management Holdings reported no remaining Applied Genetic Technologies Corporation position as of Q1 2017 after selling out during the quarter.
Cornerstone Capital Management Holdings sold 10,900 Applied Genetic Technologies Corporation shares in Q1 2017, an estimated $101K.
Cornerstone Capital Management Holdings first reported a position in Applied Genetic Technologies Corporation in Q4 2015 and held it in 5 quarters.
Cornerstone Capital Management Holdings's Applied Genetic Technologies Corporation position peaked at $260K in Q1 2016.
89 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q1 2017, filed 10 May 2017.